In the present study, we employed a murine model of chronic exogenous angiotensin II administration via daily intraperitoneal injection, which has been previously established for investigating endothelial dysfunction pathophysiology (Trejo-Moreno et al., 2021). The gene discussed is AGT; the disease is endothelial dysfunction.